ADA Scientific Sessions 2026 Abstract

The SURPASS-CVOT Retinopathy Substudy: Retinal Status after Treatment with Tirzepatide or Dulaglutide in Patients with Type 2 Diabetes and Risk for Progressive Retinopathy

By David M. D'Alessio, Zoltán Zsolt Nagy, Imre J. Pavo, Stephen J. Nicholls

Trial in peopleInterventions

The paper

David M. D'Alessio, Zoltán Zsolt Nagy, Imre J. Pavo, Stephen J. Nicholls

Durham

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, oral 1005-OR

doi.org/10.2337/db26-1005-or

Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance